Forbes William P Insider Trades

Insider Trading History

Track insider trading activity for Forbes William P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $92.8k 221,611 shares
Last Trade
Jun 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.27k 12,500 shares
$0.42
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $5.23k 12,500 shares
Last Trade
Jun 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.27k 12,500 shares
$0.42
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $73.9k 176,545 shares
Last Trade
Apr 30, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.2k 23,464 shares
$1.20
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $87.5k 209,111 shares
Last Trade
Apr 30, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.2k 23,464 shares
$1.20
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $77.7k 185,647 shares
Last Trade
Apr 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.87k 3,874 shares
$1.00
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $11.4k 27,120 shares
Last Trade
Apr 19, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.87k 3,874 shares
$1.00
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $58.7k 140,332 shares
Last Trade
Jan 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.4k 11,695 shares
$1.32
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $76.1k 181,773 shares
Last Trade
Jan 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.4k 11,695 shares
$1.32
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $78.8k 188,315 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$497k 376,629 shares
$1.32
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $13k 30,994 shares
Last Trade
Jan 19, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.77k 3,875 shares
$1.49
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $71.2k 170,078 shares
Last Trade
Jan 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.77k 3,875 shares
$1.49
$0.42
Beyond Air
Beyond Air XAIR
Director
Holding Value $0 0 shares
Last Trade
Nov 04, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$11.2k 6,000 shares
$1.86
$0.46
Beyond Air
Beyond Air XAIR
Director
Holding Value $1.73k 3,750 shares
Last Trade
Nov 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.7k 11,150 shares
$1.95
$0.46
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $63.6k 152,027 shares
Last Trade
Oct 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.6k 11,694 shares
$1.16
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $69.6k 166,203 shares
Last Trade
Oct 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.6k 11,694 shares
$1.16
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $14.6k 34,869 shares
Last Trade
Oct 19, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5k 3,874 shares
$1.29
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $64.7k 154,509 shares
Last Trade
Oct 19, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5k 3,874 shares
$1.29
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $63.1k 150,635 shares
Last Trade
Jul 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.2k 11,695 shares
$1.73
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $68.5k 163,721 shares
Last Trade
Jul 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.2k 11,695 shares
$1.73
$0.42
Heron Therapeutics
Heron Therapeutics HRTX
Evp, Chief Development Officer
Holding Value $16.2k 38,743 shares
Last Trade
Jul 19, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.48k 3,874 shares
$1.93
$0.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up